Antibiotic Irrigation for Pancreatoduodenectomy
Routine Antibiotic Irrigation in Patients Undergoing Pancreatoduodenectomy to Reduce Infection and Fistula Rates
1 other identifier
interventional
190
1 country
1
Brief Summary
The purpose of this study is to determine if the routine use of antibiotic irrigation during pancreas surgery (Whipple procedure) will decrease superficial and organ space infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable surgery
Started Nov 2014
Longer than P75 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2014
CompletedFirst Posted
Study publicly available on registry
July 10, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedResults Posted
Study results publicly available
February 23, 2022
CompletedFebruary 23, 2022
January 1, 2022
4.4 years
July 1, 2014
August 14, 2019
January 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Number of Patients With Infections
30 Days
Secondary Outcomes (1)
The Number of Patients With Fistulas
5 Days
Study Arms (2)
Polymyxin B in Normal Saline
EXPERIMENTALPolymyxin B (500,000 U) in 1 liter of 0.9% Normal Saline
Placebo: Normal Saline
PLACEBO COMPARATOR0.9 % Normal Saline
Interventions
Antibiotic irrigation via peritoneal lavage
Placebo irrigation via peritoneal lavage
Eligibility Criteria
You may qualify if:
- At least 18 years of age and older;
- Open pancreatoduodenectomy for any diagnosis
You may not qualify if:
- Pregnant;
- Prisoners;
- Patients undergoing concomitant colectomy;
- Antibiotic allergy to study medication;
- Serum creatinine \> 2.0;
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Michael House
- Organization
- Indiana University School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Michael House, MD
Indiana University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Surgery
Study Record Dates
First Submitted
July 1, 2014
First Posted
July 10, 2014
Study Start
November 1, 2014
Primary Completion
April 1, 2019
Study Completion
August 1, 2019
Last Updated
February 23, 2022
Results First Posted
February 23, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share